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Bone mineral density is not related to 
angiographically diagnosed coronary artery disease
Abstract
Based on data, there may exist an association between low bone mineral density (BMD) and atheroscle-
rosis. This study aimed to investigate the association between BMD and coronary artery disease (CAD). In
this study the possible association of BMD with CAD in 65 men with CAD and in 49 men with normal an-
giography as well as in 51 women with CAD and in 51 normal women was investigated. Both spinal and
femoral BMD values for men were higher than those of women (P<0.05). Neither femoral nor spinal BMD
values were diﬀerent in patients with or without CAD. In addition, BMD values were not associated with
the severity of CAD. Body mass index (BMI) was positively correlated with BMD both in men and women,
whereas age and anti-diabetic treatment were linked with lower BMD in women. In conclusion, in this
study CAD was not related to low BMD. However, BMI was an independent predictor of diminished BMD.
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Introduction
Although osteoporosis and coronary artery disease (CAD) share common risk fac-tors, like inflammation, a direct relationship between the two is missing [1, 2].Basic and clinical investigations have documented increased levels of osteopro-
tegrin (OPG) as well as receptor activator of nuclear factor kappa ligand (RANKL) in
atherogenesis and bone loss [1]. Aortic calcification is shown to predict bone loss and
fractures; bone resorption is also indicative of aortic calcification [2, 3]. Marcovitz et al.
(2005) primarily described that low BMD (osteoporosis and/or osteopenia) is an inde-
pendent predictive factor for CAD in ambulatory patients predominantly women [4].
Furthermore, according to angiography findings, low BMD in men is associated with
CAD complications [5]. On the other hand, some reports have failed to demonstrate a
direct relationship between low bone mineral density (BMD) and CAD or cardiovascular
risk factors in post-menopausal women [6]. Likewise, risk of death due to CAD or stroke
was not linked to low BMD among men and an increased risk of CAD and stroke in
women with low BMD was suggested, but without significant associations between
variables [7].
We aimed to undertake this study in order to add our experience on whether there
is an association between BMD and CAD in a population of men and women. 
Materials and methods
This study was performed on patients, who referred to our Institution for angiography,
suspicious of CAD. Patients with hyperparathyroidism, renal failure, active inflammatory
disease or malignancy, hormone replacement treatment or menopause and those
under treatment with corticosteroids, anticoagulants or anticonvulsants were excluded.
Overall, we studied 114 men and 102 women.  
All subjects filled a detailed questionnaire about demographic and behavioral status
as well as a medical history of conditions that could aﬀect bone mass and metabolism.
The study was approved by the Ethical Committee of Bushehr University of Medical Sci-
ences, and written informed consent was obtained from all subjects studied.
Bone mineral density
Bone mineral density was determined for the lumbar spine (L2-L4) and femoral neck using
dual-energy X-rays absorptiometry on an Osteocore II bone densitometer (Osteocore II,
France). To eliminate the inter-observer errors, the same operator tested all subjects and
results were confirmed by a nuclear medicine specialist. The precision errors were meas-
ured using the mean square method. The coeﬃcients of variation (CV) of calculations of
the lumbar spine and femoral neck were 0.9% and 1.8%, respectively. 
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Gender Age
Men Women Men Women
CAD 65 51 58.32±10.17 59.53±8.92
No CAD 49 51 53.65±9.58 52.59±9.56
Table 1. Gender, age and CAD in the subjects studied
Femoral Neck BMD
Osteoporosis Osteopenia Normal
Men Women Men Women Men Women
CAD 0 0 0 14 65 37
No CAD 0 0 0 16 49 35
Table 2. Subjects with normal or abnormal BMD and CAD
Lumbar BMD
Osteoporosis Osteopenia Normal
Men Women Men Women Men Women
CAD 35 15 7 16 23 20
No CAD 31 12 4 29 14 10
β=-0.017, P=0.886 for lumbar) nor in women (β= 0.076,
P=0.526 for femoral neck and β= 0.135, P=0.304 for lumbar).
There was no significant diﬀerence in BMD values among
the patients with diﬀerent values of CAD involvement (Table
5, P>0.05). In addition, when the data of BMD was categorized
into quartiles, we did not find a notable diﬀerence in end di-
astolic volume, end systolic volume or in ejection fraction.
In Figures 1-3 a one normal and two abnormal angiogra-
phy tests are shown. In Figures 4 and 5 a normal BMD and
an abnormal BMD are shown. 
 Discussion
Although an inflammatory process is evident for both osteo-
porosis and CAD, a direct relationship between the two is
missing. A negative correlation between the BMD and serum
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Figure 1. Normal angiography.
The BMD values for the regions of interest (ROI) were
measured by T and Z score values. T scores are measured  by
taking the diﬀerence between a patient’s BMD and the mean
BMD value in healthy young adults, which is matched for sex
and ethnic group, and presenting the diﬀerence relative to
the young adult population standard deviation (SD) [8]. 
The participants were considered as normal (T score>-1SD),
osteopenic (-1SD< T <-2.55SD) and osteoporotic (T score <-
2.5SD) according to the World Health Organization criteria
for osteoporosis [8]. 
Coronary angiography was performed with the standard
Judkin’s method [9] using angiography device (Siemens
Axiom Artis, Germany). Stenosis of more than 50% was con-
sidered as CAD. 
Statistical analysis
Linear regression analysis was performed to ascertain the as-
sociation of BMD results as a dependent variable and other
independent variables and beta as the regression coeﬃcient.
T-test was applied to analyze the diﬀerence between the nor-
mal and abnormal groups. One-way ANOVA was used to ana-
lyze BMD values in patients with diﬀerent degrees of CAD
involvement, and Kruskal-Wallis was used for interquartile
comparison of end diastolic volume (EDV), systolic volume
(ESV) and ejection fraction (EF). SPSS V. 18 was used for sta-
tistical analysis and P<0.05 was considered as significant.
Results
Overall, we included 114 men (65 with angiography-confirmed
CAD and 49 with normal angiography), as well as 102 women
(51 with CAD and 51 normal). Demographic information of the
patients is described in Table 1. Fifty nine subjects (36 men, 23
women) had hypertension, 104 (59 men, 45 women) were
smokers, and 53 (23 men, 30 women) had diabetes mellitus
(DM). There was no significant diﬀerence between men and
women regarding smoking, hypertension or DM. 
The BMD values of men and women with or without CAD
are presented in Tables 2 and 3. Overall the femoral neck
(0.891±0.187) and the lumbar (0.893±0.192) BMD values for
men were higher than for women (0.84±0.13 and 0.80±0.18,
respectively) (P<0.05). Femoral neck and lumbar BMD in CAD
patients (0.87±0.14 and 0.85±0.21, respectively) was not sig-
nificantly diﬀerent from those of normals (0.86±0.2 and
0.85±0.18). In addition, there was not a notable diﬀerence
when the BMD values were compared between CAD patients
and normals in both men and women. Moreover, the fre-
quency of CAD was not diﬀerent between men and women. 
A linear regression analysis showed that only body mass
index (BMI) was positively correlated with lumbar (β=0.28,
P<0.05) and femoral neck (β=0.36, P<0.01) BMD in men
(Table 4). In addition, BMI (positively) and age (negatively)
were associated with lumbar and femoral neck BMD in
women (P<0.05). Treatment with antidiabetic drugs had also
a negative impact on femoral neck BMD in women (β=-0.458,
P<0.001). Increase of age was also associated with increase
of CAD risk (β=0.254, P<0.01). Finally, we could not detect a
significant correlation between coronary artery disease and
BMD neither in men (β=0.157, P=0.139 for femoral neck and
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Table 3. BMD values between subjects with CAD and without CAD
Gender BMD Group N Mean±SD Mean difference P
(95% CI)
Figure 2. Abnormal angiography. Arrow indicates 99% stenosis in left anterior
descending artery (RAO- cranial view). 
Figure 3. An abnormal angiography. Arrow indicates 99% stenosis in mid-left cir-
cumflex artery (RAO-caudal view). 
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Men
Femoral Neck
Lumbar
Femoral Neck
Lumbar
CAD
No CAD
CAD 
No CAD
CAD 
No CAD
CAD 
No CAD
65
49
65
49
51
51
51
51
0.91±0.13 
0.87±0.24
0.91±0.21
0.88±0.16
0.81±0.12
0.86±0.14
0.78±0.17
0.83±0.19
-0.04 (-0.11 - 0.03)
-0.03 (-0.1 - 0.04)
0.04 (-0.01 - 0.01)
0.05 (-0.02 - 0.12)
0.25
0.43
0.12
0.18
Women
Table 4. Linear regression of diﬀerent variables as predictors for BMD
BMD
Men (79 patients) Women (48 patients)
Femoral neck Lumbar Femoral neck Lumbar
Parameter Beta P value Beta P value Beta P value Beta P value
Constant .215 .035 .000 .003
Age -.160 .192 .031 .816 -.392 .002* -.440 .001*
HTN .159 .16 .066 .599 .042 .723 .163 .215
Smoking -.008 .937 .054 .635 .053 .635 .054 .66
Anti-diabetics -.001 .994 -.082 .475 -.458 .000* -.21 .098
CAD .157 .139 -.017 .886 .076 .526 .135 .304
BMI .362 .002* .277 .03* .209 .089 .283 .037*
* Significant effect of the variable on BMD, BMI: body mass index, HTN: hypertension, Beta: regression coefficients, constant: y intercept    
Table 5. The BMD values of subjects with diﬀerent levels of CAD involvement
BMD (mean±SD)
Involved vessels Number of subjects Age Femoral neck Lumbar
Men Women Men Women
0 114 53.70±9.73 0.88±0.23 0.85±0.14 0.91±0.21 0.83±0.18
1 22 56.35±10.73 0.92±0.13 0.8±0.16 0.89±0.19 0.79±0.12
2 25 56.96±8.96 0.99±0.13 0.82±0.12 0.9±0.17 0.81±0.16
3 54 61.11±8.88 0.89±0.12 0.82±0.13 0.87±0.18 0.74±0.22
4 1 72.00 0.72±0 0 0.83±0 0
P value 0.44 0.49 0.94 0.34
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We did not find a significant diﬀerence between the BMD
values in patients with or without CAD (Table 2). In addition,
linear regression analysis revealed that the presence of CAD
could not significantly influence BMD (Table 4). Other re-
searchers described that low BMD could be an independent
predictive factor for CAD [4]. In contrast, we did not find a
significant relationship between low BMD and CAD in both
women and men. In addition, cardiovascular risk factors
such as hypertension and smoking did not show a notable
influence on our BMD findings. However the risk for both
CAD and osteoporosis was higher with increased age. Ab-
sence of direct relationship between low BMD and CAD or
cardiovascular risk factors was also reported by others in
post-menopausal women [6]. Likewise, the risk of death due
to CAD or stroke was not attributed to low BMD among men
[7]. Low BMD was found by others to be associated with in-
creased thickness of carotid intima-media as well as carotid
atherosclerosis in post-menopausal women [14, 15]. Sub-
clinical cardiovascular disease was also reported to be re-
lated with increased bone loss as well as with a fracture risk
[16]. As the above indicate, the shared pathophysiological
mechanisms for bone loss and coronary CAD are not fully
clarified; yet, age, estrogen deficiency and inflammation ap-
pear to be the most significant factors that might explain
this association [17-20].
Other researchers reported that patients with advanced
coronary stenosis (three-vessels) showed a lower BMD in the
femoral neck but not in the spine [17]. In contrast, we did
not observe a diﬀerence in the BMD values, either in the
lumbar area or the femoral head, among our patients with
diﬀerent levels of coronary artery involvement (Table 5). The
above researchers also described that CAD patients with low
BMD had a lower level of testosterone and testosterone/
estradiol ratio but similar levels of estradiol, estrone and de-
hydroepiandrosterone sulfate (DHEA-S) [17]. Furthermore,
in osteoporotic or osteopenic women a higher prevalence
of atherosclerotic vascular disease, including CAD was sug-
gested [18].
We also noticed that administration of anti-diabetic drugs
was associated with low BMD in women. Insulin deficit and
hyperglycemia in diabetic patients can alter bone metabo-
lism, thereby produce a higher risk of fractures. Imbalance
of the AGE/RAGE axis as described above and oxidative
stress can alter osteocalcin production and osteoblastic ac-
tivity. In addition, Peroxisome proliferator-activated receptor
(PPAR) agonists including the anti-diabetic agents thiazo-
lidinediones are thought to significantly influence bone den-
sity and increase the risk of osteoporosis, especially in older
women [19-21].
In addition, we found a wide discrepancy between BMD
values of lumbar and femur regions. This  discordance may
be associated to the skeleton's natural adaptive reaction to
normal external and internal conditions and forces, eg, over-
weight, or to the dissimilarity in bone loss velocity between
the trabecular and the cortical bone, eg, during menopause
or after the use of steroids; secondarily to a disease yielding
a falsely increased lumbar T score, like in vertebral osteophy-
tosis, facet sclerosis or syndesmophytes; artefactual; and
lastly, to technical errors, technicians variability or move-
ments of the subjects tested [22-25]. Others [26] have de-
Figure 4. A normal BMD value in either the lumbar (T score= -0.67) or the femoral
region (T score= 0.46).
Figure 5. An abnormal BMD. It showed osteopenia in the lumbar region (T score=
-2.35) but normal BMD value in the femoral region (T score= -0.92).
levels of osteoprotegerin (OPG) in postmenopausal women
without hormone replacement treatment (HRT) has been re-
ported. However, such a relationship could not be estab-
lished for men, premenopausal women, or postmenopausal
women with HRT [10].
In accelerated atherosclerosis inflammatory process is
supported by enhanced endothelial cell activation and the
RANKL/OPG/RANK axis [1, 11, 12]. Osteoprotegrin (OPG) in-
hibits osteoclast diﬀerentiation through inhibition of the in-
teraction between receptor-activator of nuclear factor
kappa-B (RANKL) and its membrane receptor (RANK). In ad-
dition, this system is also involved in atherosclerosis through
promotion of cellular inflammatory response, matrix met-
aloproteases, or prothrombotic activity [1]. Elevated levels
of OPG are also associated with acute coronary symptoms
and coronary calcification [1, 13]. Bakhireva et al. (2008)
noted that increased BMD was associated with a lower risk
of coronary artery calcification [12-17].
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tected that 18F-FDG uptake in aortic segments increases with
age irrespective of genders. In this study, we did not investi-
gate a possible correlation between BMD, hormones and
aortic calcification. As osteoporosis and CAD share molecu-
lar risk factors like RANKL, an association between BMD
scores and coronary calcium score seems to be relevant even
before the involvement of vessels becomes detectable in an-
giography.
In conclusion, there was not a significant diﬀerence be-
tween the BMD values of subjects with or without CAD. In
addition BMD values of patients with diﬀerent degrees of
CAD were not notably diﬀerent. Furthermore, BMI was pos-
itively correlated with BMD in men and women. Treatment
with anti-diabetic drugs and age were negatively associated
with BMD in women.
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